Stay up to date

Is IVDR Wearing You Down? A Webinar Reviews 2022 for IVD Manufacturers
By Sean Smith on December 9, 2022

IVDR 2022: The Year In Review Webinar with IVD Insider Carlos Galamba Is the In Vitro Diagnostic Regulation (IVDR) wearing you down? If so, you’re...

Continue Reading
11 Top Innovators in Real-World Evidence to Follow in 2023
By Sean Smith on December 8, 2022

Huma.AI Is Among PharmStars Fall 2022 Graduates Today PharmStars, the pharma-focused accelerator for digital health startups, announced the...

Continue Reading
How Machine Learning Improves Real-World Evidence
By Dylan James Brock on November 17, 2022

Can Machines Understand Cause and Effect? In the simplest terms, machine learning (ML) is based on the ability of algorithms to learn from data. To...

Continue Reading
How Integration of Diverse Data Powers Drug Discovery and Development
By Dylan James Brock on November 15, 2022

Over the past decade, artificial intelligence (AI) and machine learning (ML) has become the breakthrough technology most likely to transform how...

Continue Reading
How to Jumpstart Patient Recruitment with Machine Learning
By Dylan James Brock on November 10, 2022

Making the Most of the Data Available is the Key to Driving Recruitment Clinical operations professionals must extract the information they need to...

Continue Reading
9 Ways to Design Clinical Trials with Diversity in Mind
By Dylan James Brock on November 9, 2022

Leveraging Clinical Intelligence to Meet New Requirements for Diversity Properly representing patient populations in clinical trials means taking on...

Continue Reading
3 Critical Steps to Optimize Machine Learning for Clinical Development
By Dylan James Brock on November 7, 2022

Why "Resistance to Change" Is the Biggest Blocker to Clinical Development Innovation When we talk about optimizing clinical development, we're...

Continue Reading
New Huma.AI Clinical Development Solution Provides Transparent Trial, PI, and Patient Data to Reveal Insights and Opportunities–Instantly
By Lana Feng, Ph.D. on October 17, 2022

New eBook Reveals How Data-Driven Clinical Intelligence Empowers Sponsors Using Everyday Language Oct. 14, 2022, Palo Alto, CA - Huma.AI, a...

Continue Reading
IVDR Insider Explains 5 Critical Impacts of the EU Clinical Evidence Requirements
By Sean Smith on October 7, 2022

We recently published an exclusive MedTech Intelligence interview with Carlos Galamba, Vice President, Intelligence and Innovation with RQM+. Galamba...

Continue Reading
Huma.AI Announces Appointment of Karen Drexler to Its Board of Directors and Jean-Olivier Racine to Its Advisory Board
By Lana Feng, Ph.D. on July 19, 2022

New board members to provide expertise and guidance to help set strategic direction for Huma.AI into the future – appointments come during key phase...

Continue Reading